Cadrenal Therapeutics, Inc.
CVKD
$13.25
$0.92977.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.57M | 7.34M | 10.02M | 4.36M | 5.04M |
| Total Receivables | 19.00K | 24.70K | 38.20K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 358.40K | 575.60K | 42.30K | 191.70K | 234.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 23.90K | 8.50K | 14.40K | 116.90K | 171.40K |
| Total Current Assets | 5.97M | 7.94M | 10.11M | 4.67M | 5.44M |
|
|
|||||
| Total Current Assets | 5.97M | 7.94M | 10.11M | 4.67M | 5.44M |
| Net Property, Plant & Equipment | 4.30K | 4.70K | 6.90K | 3.00K | 9.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.20K | 3.80K | 3.80K | 3.80K | 3.80K |
| Total Assets | 5.98M | 7.95M | 10.12M | 4.68M | 5.46M |
|
|
|||||
| Total Accounts Payable | 895.60K | 1.28M | 1.50M | 496.80K | 759.50K |
| Total Accrued Expenses | 783.90K | 561.80K | 1.18M | 767.90K | 696.60K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 2.20K | 8.80K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.68M | 1.84M | 2.68M | 1.27M | 1.46M |
|
|
|||||
| Total Current Liabilities | 1.68M | 1.84M | 2.68M | 1.27M | 1.46M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.68M | 1.84M | 2.68M | 1.27M | 1.46M |
|
|
|||||
| Common Stock & APIC | 37.53M | 35.68M | 33.16M | 24.95M | 23.12M |
| Retained Earnings | -33.24M | -29.57M | -25.72M | -21.54M | -19.13M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.30M | 6.11M | 7.44M | 3.41M | 3.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.30M | 6.11M | 7.44M | 3.41M | 3.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.30M | 6.11M | 7.44M | 3.41M | 3.99M |
|
|
|||||